Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


16.09.2019

1 Ann Surg Oncol
1 Anticancer Res
1 Br J Dermatol
1 Clin Cancer Res
1 Cutis
1 Int J Cancer
3 J Am Acad Dermatol
1 J Clin Oncol
1 J Immunother
1 J Invest Dermatol
3 Melanoma Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. HENDERSON MA, Gyorki D, Burmeister BH, Ainslie J, et al
    Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.
    Ann Surg Oncol. 2019 Sep 12. pii: 10.1245/s10434-019-07810.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. ZIPPEL D, Friedman-Eldar O, Rayman S, Hazzan D, et al
    Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic Melanoma.
    Anticancer Res. 2019;39:4995-5001.
    PubMed     Text format     Abstract available


    Br J Dermatol

  3. CUST AE, Badcock C, Smith J, Thomas NE, et al
    A risk prediction model for development of subsequent primary melanoma in a population-based cohort.
    Br J Dermatol. 2019 Sep 14. doi: 10.1111/bjd.18524.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  4. THAKUR R, Laye JP, Lauss M, Diaz JMS, et al
    Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma.
    Clin Cancer Res. 2019 Sep 12. pii: 1078-0432.CCR-18-3659.
    PubMed     Text format     Abstract available


    Cutis

  5. YANG JY, Cho SY, Kim YC
    Irregularly hyperpigmented plaque on the right heel.
    Cutis. 2019;103:E13-E15.
    PubMed     Text format    


    Int J Cancer

  6. CERVENKA I, Al Rahmoun M, Mahamat-Saleh Y, Fournier A, et al
    Exogenous Hormone Use and Cutaneous Melanoma Risk in Women: The European Prospective Investigation Into Cancer and Nutrition.
    Int J Cancer. 2019 Sep 10. doi: 10.1002/ijc.32674.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  7. ROGERS H, Beveridge M, Puente J, Wixson S, et al
    Incidence of non-melanoma skin cancer in the US population aged 65 years and older, 2014.
    J Am Acad Dermatol. 2019 Sep 6. pii: S0190-9622(19)32687.
    PubMed     Text format    

  8. LALLAS A, Apalla Z, Kyrgidis A, Papageorgiou C, et al
    Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring.
    J Am Acad Dermatol. 2019 Sep 6. pii: S0190-9622(19)32682.
    PubMed     Text format     Abstract available

  9. BASU P, Beckles A, Porter ML, Olbricht S, et al
    Non-melanoma skin cancers are more likely to be untreated in elderly patients.
    J Am Acad Dermatol. 2019 Sep 13. pii: S0190-9622(19)32746.
    PubMed     Text format    


    J Clin Oncol

  10. REGAN MM, Werner L, Rao S, Gupte-Singh K, et al
    Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.
    J Clin Oncol. 2019 Sep 9:JCO1900345. doi: 10.1200/JCO.19.00345.
    PubMed     Text format     Abstract available


    J Immunother

  11. JAIN V, Venigalla S, Reddy VK, Lukens JN, et al
    Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint Inhibitors.
    J Immunother. 2019 Sep 6. doi: 10.1097/CJI.0000000000000294.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  12. SEITZ-ALGHROUZ R, Hidalgo JV, Kayser C, Kreutz C, et al
    BRAF V600E Mutations in Nevi and Melanocytic Tumors of Uncertain Malignant Potential (MELTUMPs).
    J Invest Dermatol. 2018 May 15. pii: S0022-202X(18)31973.
    PubMed     Text format    


    Melanoma Res

  13. SALGADO C, Kwesi-Maliepaard EM, Jochemsen AG, Visser M, et al
    A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.
    Melanoma Res. 2019 Sep 12. doi: 10.1097/CMR.0000000000000640.
    PubMed     Text format     Abstract available

  14. SAXENA R, Wang Y, Mier JW
    CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors.
    Melanoma Res. 2019 Sep 12. doi: 10.1097/CMR.0000000000000639.
    PubMed     Text format     Abstract available

  15. GAUCI ML, Boudou P, Squara PA, Delyon J, et al
    Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients.
    Melanoma Res. 2019;29:328-332.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: